Insights on the Nucleic Acid Isolation & Purification Global Market to 2027 - Molecular Diagnostics and Personalized Medicine Presents Opportunities - ResearchAndMarkets.com
06 Dec 2022
DUBLIN--(BUSINESS WIRE)--The "Global Nucleic Acid Isolation & Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Diagnostics), End-user (Pharma, Biotech), and Region - Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
'Global Nucleic Acid Isolation & Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Diagnostics), End-user (Pharma, Biotech), and Region - Forecast to 2027'
The global nucleic acid isolation and purification market is projected to reach USD 9.2 billion by 2027 from USD 6.3 billion in 2022, at a CAGR of 7.9% during the forecast period.
The instruments segment will grow at the highest rate during the forecast period
On the basis of product, the nucleic acid isolation and purification market is segmented into kits, reagents, and instruments. In 2021, kits were the largest product segment in the market. Growth in this market can be attributed to the continuous focus of key market players on developing and launching new and advanced kits. However, the instruments segment is expected to grow at the highest rate during the forecast period.
By type, the plasmid DNA isolation and purification segment accounted for the largest share of the nucleic acid isolation and purification market in 2021
On the basis of type, the global nucleic acid isolation and purification market is segmented into plasmid DNA isolation and purification, total RNA isolation and purification, circulating nucleic acid isolation and purification, genomic DNA isolation and purification, messenger RNA isolation and purification, microRNA isolation and purification, PCR cleanup, and other nucleic acid isolation and purification types.
The plasmid DNA isolation segment accounted for the largest share of the nucleic acid isolation and purification market in 2021.The large share of this market segment can be attributed to the wide use of purified plasmid DNA in a variety of downstream applications, such as PCR, sequencing, expression of proteins, gene therapy, and transfection.
The market in the Asia Pacific is projected to witness the highest growth rate during the forecast period (2020-2027)
North America accounted for the largest share of the nucleic acid isolation and purification market in 2021. Significant R&D spending in biotechnology and pharmaceutical companies, the large size of the biotechnology industry, technological advancements, and government support in the region are the key factors driving the growth of the nucleic acid isolation and purification market in North America.
On the other hand, the Asia Pacific is projected to register the highest growth during the forecast period. This large share can be attributed to factors such as the increasing number of genomic projects and increasing R&D investments by pharmaceutical & biotechnology companies in this region.
Market Dynamics
Increasing R&D Activities
Technological Advancements and Increasing Automation
Restraints
High Cost of Automated Instruments
Opportunities
High Scope of Growth in Emerging Economies
Improving Regulatory and Reimbursement Scenario
Molecular Diagnostics and Personalized Medicine
Trends
Increase in Government Funding
Companies Mentioned
3D Blackbio Biotech India Ltd.
Biovision
F. Hoffmann-La Roche AG
Genaxxon Bioscience GmbH
Merck KGaA
New England Biolabs
Qiagen
For more information about this report visit https://www.researchandmarkets.com/r/pdt4js
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.